We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-6.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$24.5B
AUM Growth
-$1.55B
Cap. Flow
+$503M
Cap. Flow %
2.05%
Top 10 Hldgs %
14.23%
Holding
2,483
New
111
Increased
1,136
Reduced
972
Closed
225

Sector Composition

Rank Sector Weight
1 Healthcare 9.12%
2 Technology 8.89%
3 Financials 8.43%
4 Consumer Staples 7.6%
5 Industrials 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENOV icon
1026
Enovis
ENOV
$1.4B
$2.86M 0.01%
55,631
-42,502
-43% -$2.82M
USA icon
1027
Liberty All-Star Equity Fund
USA
$1.86B
$2.84M 0.01%
559,649
+15,395
+3% +$84.6K
HUM icon
1028
Humana
HUM
$46.3B
$2.84M 0.01%
15,878
-1,647
-9% -$304K
MFA
1029
MFA Financial
MFA
$919M
$2.84M 0.01%
104,283
+4,991
+5% +$146K
IVZ icon
1030
Invesco
IVZ
$14B
$2.83M 0.01%
90,742
-27,189
-23% -$967K
SOR
1031
Source Capital
SOR
$383M
$2.83M 0.01%
41,720
+6,108
+17% +$436K
TRIP icon
1032
TripAdvisor
TRIP
$1.26B
$2.82M 0.01%
44,743
-10,973
-20% -$830K
RYL
1033
DELISTED
RYLAND GROUP INC
RYL
$2.81M 0.01%
68,837
+12,714
+23% +$567K
CBSH icon
1034
Commerce Bancshares
CBSH
$8.44B
$2.81M 0.01%
105,499
+11,312
+12% +$304K
FTC icon
1035
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
$2.81M 0.01%
61,503
+15,388
+33% +$745K
WST icon
1036
West Pharmaceutical
WST
$24.8B
$2.81M 0.01%
51,911
-4,355
-8% -$254K
INGR icon
1037
Ingredion
INGR
$6.53B
$2.8M 0.01%
32,108
+1,666
+5% +$143K
BKU icon
1038
Bankunited
BKU
$3.34B
$2.8M 0.01%
78,366
+2,794
+4% +$101K
COO icon
1039
Cooper Companies
COO
$14.9B
$2.79M 0.01%
75,016
-17,632
-19% -$731K
THRM icon
1040
Gentherm
THRM
$1.27B
$2.78M 0.01%
61,890
+1,238
+2% +$59.3K
TRCO
1041
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$2.78M 0.01%
78,090
+35,354
+83% +$1.57M
KRC icon
1042
Kilroy Realty
KRC
$4.32B
$2.77M 0.01%
42,555
+2,322
+6% +$159K
JQC icon
1043
Nuveen Credit Strategies Income Fund
JQC
$712M
$2.77M 0.01%
347,427
+39,800
+13% +$335K
GYLD icon
1044
Arrow Dow Jones Global Yield ETF
GYLD
$38.1M
$2.76M 0.01%
144,038
+10,402
+8% +$219K
BBDC icon
1045
Barings BDC
BBDC
$980M
$2.76M 0.01%
167,588
-12,976
-7% -$262K
MCO icon
1046
Moody's
MCO
$82.8B
$2.76M 0.01%
28,120
+215
+0.8% +$22.9K
DOG
1047
ProShares Short Dow30
DOG
$86.9M
$2.74M 0.01%
+27,990
New +$2.64M
PCY icon
1048
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
$2.74M 0.01%
99,768
-54,740
-35% -$1.51M
NORW icon
1049
Global X MSCI Norway ETF
NORW
$87M
$2.73M 0.01%
126,396
+5,244
+4% +$121K
GWR
1050
DELISTED
Genesee & Wyoming Inc.
GWR
$2.73M 0.01%
46,278
-29,047
-39% -$2M

Similar funds

Raymond James & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Raymond James & Associates held 2,483 positions worth $24.5B, down 5.9% from $26.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James & Associates's Q3 2015 filing shows 111 new, 1,136 increased, 972 reduced and 225 closed positions. Its largest new stake was Camden Property Trust: 204,814 shares worth $15.1M. The largest sale was KRAFT FOODS GROUP INC COM STK (VA), an estimated $138M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 9.2% a quarter earlier, followed by Technology and Financials.

  • Raymond James & Associates's largest Q3 2015 buy was Camden Property Trust: 204,814 shares worth $15.1M.
  • Raymond James & Associates added most to ExxonMobil in Q3 2015, an estimated $88.7M increase.
  • Raymond James & Associates's biggest Q3 2015 reduction was TotalEnergies, cutting an estimated $63.3M.
  • Raymond James & Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $138M.
  • Raymond James & Associates's ten largest holdings make up 14% of its $24.5B portfolio in Q3 2015.
  • Raymond James & Associates opened 111 new positions and closed 225 in Q3 2015.
  • Raymond James & Associates's portfolio value fell 5.9% quarter-over-quarter to $24.5B.

Based on Raymond James & Associates's 13F filing for Q3 2015, filed 13 Nov 2015.